Literature DB >> 11307617

alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei.

E Braak1, D Sandmann-Keil, U Rüb, W P Gai, R A de Vos, E N Steur, K Arai, H Braak.   

Abstract

Advanced silver stains and immunohistochemical reactions against alpha-synuclein were used to detect Parkinson's disease-related cytoskeletal abnormalities in select lower brain stem nuclei. Various types of inclusion bodies including inconspicuous and heretofore unnoted granular particles and thread-like Lewy neurites were visualized. Of the nuclei investigated (gigantocellular reticular nucleus, bulbar raphe nuclei, coeruleus-subcoeruleus area), only lipofuscin- or neuromelanin-laden neuronal types showed a propensity to develop the pathological changes. Neuronal types devoid of pigment deposits remained free of the cytoskeletal abnormalities. Fine, dust-like particles and small globular Lewy bodies were encountered solely within the limits of intraneuronal lipofuscin or neuromelanin deposits.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307617     DOI: 10.1007/s004010000247

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  48 in total

1.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

Review 2.  Dynamic structural flexibility of α-synuclein.

Authors:  Danielle E Mor; Scott E Ugras; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Neurobiol Dis       Date:  2015-12-31       Impact factor: 5.996

Review 3.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

Review 4.  The pontine REM switch: past and present.

Authors:  Patrick M Fuller; Clifford B Saper; Jun Lu
Journal:  J Physiol       Date:  2007-09-20       Impact factor: 5.182

5.  Deep Brain Stimulation associated gliosis: A post-mortem study.

Authors:  Vinata Vedam-Mai; Cooper Rodgers; Ashley Gureck; Michael Vincent; Gianna Ippolito; Ahmad Elkouzi; Anthony T Yachnis; Kelly D Foote; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2018-04-04       Impact factor: 4.891

Review 6.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

7.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

8.  Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Authors:  Laura M Butkovich; Madelyn C Houser; Termpanit Chalermpalanupap; Kirsten A Porter-Stransky; Alexa F Iannitelli; Jake S Boles; Grace M Lloyd; Alexandra S Coomes; Lori N Eidson; Maria Elizabeth De Sousa Rodrigues; Danielle L Oliver; Sean D Kelly; Jianjun Chang; Nora Bengoa-Vergniory; Richard Wade-Martins; Benoit I Giasson; Valerie Joers; David Weinshenker; Malú Gámez Tansey
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

9.  Parkinson's disease: is it a toxic syndrome?

Authors:  Seham A Gad Elhak; Abdel Aziz A Ghanem; Hassan Abdelghaffar; Sahar El Dakroury; Mohamed M Salama
Journal:  Neurol Res Int       Date:  2010-09-05

10.  Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance.

Authors:  Charles R Arthur; Stephanie L Morton; Lisa D Dunham; Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2009-09-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.